Tweet
ARMENIA TO FOCUS ON DEVELOPING PHARMACEUTICAL INDUSTRY EXPORTS
IHS Global Insight
September 19, 2013
Kavita Rainova
The Armenian government is looking to simplify the procedures for
granting licences to enterprises within healthcare with the aim of
simplifying the process of starting a business as well as reducing
bureaucracy, reportsYerkramas, citing the director of the country's
National Centre for Legislation Regulation, Armen Egiazaryan.
Furthermore, pharmaceutical industry is among the industries included
in the country's strategies for export-oriented industry development;
these are the strategies, as reported by the source, which have
contributed to the increase of Armenia's pharmaceutical exports. In
the period from January to May, exports grew 41.8% year-on-year (y/y)
to AMD963 million (USD2.35 million), with exports to the Commonwealth
Independent States (CIS) increasing by 86% y/y AMD632 million.
Pharmaceutical production increased 29.4% y/y to AMD1.9 billion.
Significance:Growth in pharmaceutical production follows the previously
reported 5.3% y/y increase for the period from January to September
2013. At the time, around 50% of the country's pharmaceutical
production was exported. In terms of developing exports, the
government's plan to implement good manufacturing practice (GMP)
standards reflects this aim, given that the implementation of the
latter would enable Armenian products to access the European market,
thereby helping to further boost pharmaceutical exports. Although
the standards were expected to be implemented this year, it remains
unclear whether or not they have indeed been implemented (seeArmenia:
7 November 2012:). Nonetheless, the current development potentially
points to the government's continuing intent to enable and support
the country's pharmaceutical exports.
From: Emil Lazarian | Ararat NewsPress
IHS Global Insight
September 19, 2013
Kavita Rainova
The Armenian government is looking to simplify the procedures for
granting licences to enterprises within healthcare with the aim of
simplifying the process of starting a business as well as reducing
bureaucracy, reportsYerkramas, citing the director of the country's
National Centre for Legislation Regulation, Armen Egiazaryan.
Furthermore, pharmaceutical industry is among the industries included
in the country's strategies for export-oriented industry development;
these are the strategies, as reported by the source, which have
contributed to the increase of Armenia's pharmaceutical exports. In
the period from January to May, exports grew 41.8% year-on-year (y/y)
to AMD963 million (USD2.35 million), with exports to the Commonwealth
Independent States (CIS) increasing by 86% y/y AMD632 million.
Pharmaceutical production increased 29.4% y/y to AMD1.9 billion.
Significance:Growth in pharmaceutical production follows the previously
reported 5.3% y/y increase for the period from January to September
2013. At the time, around 50% of the country's pharmaceutical
production was exported. In terms of developing exports, the
government's plan to implement good manufacturing practice (GMP)
standards reflects this aim, given that the implementation of the
latter would enable Armenian products to access the European market,
thereby helping to further boost pharmaceutical exports. Although
the standards were expected to be implemented this year, it remains
unclear whether or not they have indeed been implemented (seeArmenia:
7 November 2012:). Nonetheless, the current development potentially
points to the government's continuing intent to enable and support
the country's pharmaceutical exports.
From: Emil Lazarian | Ararat NewsPress